Respondents’ preferences for types and forms of cannabis used for sleep
| Types and forms of products | % | Cannabis constituents | % |
|---|---|---|---|
| Types of cannabis products (N = 1,186) | Cannabinoids used for sleep (N = 624) | ||
| High THC | 60.0% | THC | 78.8% |
| Balanced THC:CBD | 21.7% | CBD | 47.1% |
| Not sure | 6.4% | Cannabinol (CBN) | 18.1% |
| High CBD | 5.3% | Terpenes used for sleep (N = 624) | |
| Doesn’t matter | 4.2% | Myrcene | 49.0% |
| Form of cannabis product (N = 1,216) | Linalool | 26.9% | |
| Joints | 46.1% | Limonene | 24.7% |
| Oil | 42.5% | Beta caryophyllene | 19.1% |
| Vape flower | 42.6% | Terpinolene | 13.5% |
| Edibles | 34.9% | Humulene | 7.1% |
| Vape pen | 33.9% | Nerolidol | 4.0% |
| Capsules | 14.6% | ||
AS: Data curation, Formal analysis, Writing—original draft, Writing—review & editing. CC: Data curation, Formal analysis, Visualization, Project administration, Supervision, Writing—original draft, Writing—review & editing.
The authors declare they have no conflicts of interest.
The Washington State University Office of Research Assurances determined that this study was exempt from the need for review by the Institutional Review Board (IRB).
Strainprint® obtained informed consent from all participants as part of the terms of use of their platform.
Not applicable.
Data are available upon request to carrie.cuttler@wsu.edu.
Not applicable.
© The Author(s) 2023.